Aprea Therapeutics, Inc. (APRE)

Aprea Therapeutics Revenue

Aprea Therapeutics had revenue of $118.11K in the quarter ending June 30, 2025, a decrease of -78.97%. This brings the company's revenue in the last twelve months to $841.01K, down -34.07% year-over-year. In the year 2024, Aprea Therapeutics had annual revenue of $1.50M with 157.63% growth.

• Revenue (ttm): $841.01K
• Revenue Growth: -34.07%
• P/S Ratio: 10.37
• Revenue / Employee: $105,127
• Employees: 8
• Market Cap: 8.64M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.50M	919.35K	157.63%
Dec 31, 2023	583.23K	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.